Announcing what’s next changes what customers do today.

Who is writing your “should I wait” answer?

Beta Bionics just told investors that some customers may wait for its next product, and up to $8.5 million of Q4 revenue could slip because of it.

Mint, its first patch pump, was cleared in September. The full launch isn’t until Q1 2027. That’s months of customers asking one question: “Should I wait?”

There’s a name for this: the Osborne effect. Announce what’s coming, and customers stop buying what’s here.

Your next launch could do the same thing to you. And if your reps don’t have a good answer, customers will make up their own.

Tandem saw this coming. When it announced its t:slim X2 pump in 2016, it announced an upgrade program in the same release, months before launch. In 2023, it offered recent t:slim X2 buyers a $199 switch to its new Mobi pump. Both times, the idea was to make buying now a safe choice.

Before your next announcement, have these ready:
1. A fit-based answer. Who is each product right for? Wait or buy now should depend on the patient, not the calendar.

2. A protection for buyers today. A switch path, or a clear statement of what you can and can’t promise.

3. Honest timing and supply. If availability will be limited at launch, say so.

4. One script. Every customer-facing team gives the same answer.

Write the “should I wait?” answer before anyone asks. Don’t let the first answer come from a customer’s guess.